Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2018
At a glance
- Drugs OC-02 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Oyster Point Pharmaceuticals
- 27 Jun 2018 According to an Oyster Point Pharma media release, data from this trial will be presented at an upcoming medical meeting.
- 13 Jun 2018 Status changed from active, no longer recruiting to completed.
- 17 Apr 2018 Status changed from recruiting to active, no longer recruiting.